N-of-1 trial of low-dose methotrexate and/or prednisolone in lieu of anti-CCP, MRI, or ultrasound, as first option in suspected rheumatoid arthritis?

J Rheumatol. 2007 Feb;34(2):250-2.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies / blood
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / diagnosis*
  • Arthritis, Rheumatoid / drug therapy*
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Early Diagnosis
  • Humans
  • Joints / diagnostic imaging
  • Joints / pathology
  • Magnetic Resonance Imaging
  • Methotrexate / therapeutic use*
  • Peptides, Cyclic / immunology
  • Prednisolone / therapeutic use*
  • Ultrasonography

Substances

  • Anti-Inflammatory Agents
  • Antibodies
  • Antirheumatic Agents
  • Peptides, Cyclic
  • cyclic citrullinated peptide
  • Prednisolone
  • Methotrexate